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Abstract
Background: Monokines induced by interferon-gamma/Chemokine (C-X-C motif) ligand 9 (MIG/CXCL9), thymus
and activation-regulated chemokine/Chemokine (C-C motif) ligand 17 (TARC/CCL17) are chemotactic factors that
specifically collect and activate leukocytes, which are considered as chemoattractants of T helper cells. In the present
study, we have investigated the effects of T helper type-1 (Th1) cells and T helper type-2 (Th2) cells in Kawasaki disease
(KD) by determining plasma levels of MIG/CXCL9 and TARC/CCL17 and exploring the relationship between MIG/CXCL9,
TARC/CCL17 levels and coronary artery lesions (CAL).
Methods: Forty-three children patients with KD and 19 healthy controls were included in this study. General
characteristics were obtained from all subjects. Plasma concentrations of chemotactic factors of MIG/CXCL9 and TARC/
CCL17 were measured by enzyme-linked immunosorbent assay (ELISA) for all subjects.
Results: Plasma levels of MIG/CXCL9, TARC/CCL17, and the ratios of MIG/TARC were significantly elevated in pediatric
patients with KD compared to those in the control group. There were also significantly higher levels of MIG/CXCL9, TARC/
CCL17, MIG/TARC ratios and prominently lower hemoglobin (Hb) levels in KD with CAL compared to KD without
coronary artery lesions (NCAL). Hb was significantly decreased and plasma MIG/CXCL9 levels had a significantly negative
correlation with CRP in KD with CAL patients (KD-CAL), whereas a positive correlation of plasma MIG/CXCL 9 with WBC
was observed in KD without CAL patients (KD-NCAL).
Conclusion: Th1 and Th2 cells may be involved in an imbalanced activation in pediatric KD patients during an acute
period of the disease. Furthermore, immune lesions of vessels in KD patients may be mediated by the imbalanced
activation of Th1 and Th2 cells.
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Background
Kawasaki disease (KD), also called mucocutaneous lymph-
node syndrome (MCLS), was firstly described in 1967 [1].
It is a kind of self-limited systemic vasculitis characterized
by a constellation of clinical signs and symptoms. The tar-
get vessels are small and medium-sized arteries, especially
coronary arteries. Studies suggested that 15 %–25 %
children with KD resulted in coronary artery lesions, if
they wouldn’t get timely treatment [2]. KD has become
the leading cause of acquired heart disease in children in
developed countries.
The pathogenesis of KD has not been clearly identified
yet. Many studies have revealed that super-antigens of
infections could trigger the immunoreaction in KD
resulting in the changes of a series of inflammatory fac-
tors, such as white blood cells (WBC), C-reactive protein
(CRP) and erythrocyte sedimentation rate (ESR). T cells
activation has been reported to be participated in the
immunological pathogenesis [3, 4], and some pro-
inflammatory cytokines of T cells, such as interleukin-4
(IL-4), interferon-gamma (IFN-γ), were changed in acute
KD. However, little is known in KD patients about the
chemotactic factors of T helper type-1 cells (Th1) and T
helper type-2 cells (Th2), plasma monokines induced by
interferon-gamma/Chemokine (C-X-C motif ) ligand 9
(MIG/CXCL9) and thymus and activation-regulated che-
mokine/Chemokine (C-C motif ) ligand 17 (TARC/
CCL17). Lee CP et al. found that plasma TARC/CCL17
levels were higher in KD before immuoglobulin (IVIG)
treatment compared to those in controls. However, the
plasma TARC/CCL17 levels decreased significantly in
KD after IVIG treatment [5]. No data about plasma
MIG/CXCL9 levels have been reported so far, and little
is known about the relationship between plasma MIG/
CXCL9, TARC/CCL17 levels and coronary artery lesions
(CAL) in KD patients. In the present study, we have
measured plasma concentrations of MIG/CXCL9 and
TARC/CCL17 in KD patients to reveal whether these
chemotactic factors are involved in the function of T
helper cells, and whether the balance between Th1 cells
and Th2 cells is altered in KD patients.
Methods
Subjects and data collection
We have enrolled KD patients before intravenous im-
munoglobulin therapy and healthy children as controls
at Children’s Hospital of Chongqing Medical University,
Chongqing, P.R. China. The study groups included 43
KD patients (22 males and 21 females, average age 2.98
± 1.91 years) and 19 healthy controls (12 males and 7 fe-
males, average age 3.37 ± 3.02 years). All of the KD pa-
tients were identified according to the criteria proposed
by the Japanese Circulation Society Joint Working
Group [6]. These KD patients were confirmed without
any other associated immunological diseases. The study
was approved by the Ethics Committee of Children’s
Hospital, Chongqing Medical University, and written in-
formed consents were obtained from the parents of all
subjects.
The KD patients had echocardiography within 2 weeks
from the onset. The echocardiographic diagnosis met the
criteria proposed by the Japanese Kawasaki Disease Re-
search Committee [7]. According to echocardiography pa-
rameters, 43 KD patients were divided into two groups,
KD without coronary artery lesions (KD-NCAL)
group (n = 21) and KD with coronary artery lesions
(KD-CAL) group (n = 22). As we enrolled the study
subjects in only 3 month, our coronary artery lesions
morbidity rate was not consistent with the annual
rate reported before but higher than that. These KD
children were treated with 2 g/kg intravenous im-
munoglobulin and oral aspirin after admission.
White blood cells (WBC) counts, platelets (Plt) counts,
percentage of neutrophils (N %), percentage of leukomo-
nocytes (L %), hemoglobin (Hb), hematocrit (Hct), C-
reactive protein (CRP), erythrocyte sedimentation rate
(ESR), aspartate aminotransferase (AST), creatine kinase-
MB (CK-MB) were obtained from all KD subjects; blood
samples were drawn before intravenous immunoglobulin
administration.
Sample collection and processing
Venous blood samples were collected from KD patients
before intravenous immunoglobulin administration on the
day of admission using an ethylene diamine tetraacetic
acid (EDTA) tube. And then the blood samples were cen-
trifuged to separate plasma immediately at speed of 3000
revolutions/min for 5 min. The same proceeds have been
done to obtain plasma samples from the healthy controls.
All of the plasma samples were stored at –80 °C centigrade.
Measurement of plasma MIG/CXCL9 and TARC/CCL17
levels
Plasma levels of MIG/CXCL9 and TARC/CCL17 in KD
patients and healthy controls were determined by com-
mercial enzyme-linked immunosorbent assay (ELISA)
kits (Shanghai Hushang Biotechnology Co., LTD, Shang-
hai, China). The procedures were done following the
manufacturers’ instructions. MIG/CXCL9 and TARC/
CCL17 standards were run on micro-test plates, and the
antigen concentrations (MIG/CXCL9: ng/L, TARC/
CCL17: pg/ml) were determined from the standard
curves by the micro-plate reader (Bioteck Epoch, US).
All of the samples were measured in duplicate.
Statistical analysis
Plasma levels of MIG/CXCL9 and TARC/CCL17 were
analyzed as quantitative traits. All of the values are
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described as mean ± standard deviation (SD) or number
and percent (n, %). Comparisons of frequencies between
groups were analyzed using χ2 text. Differences between
groups were assessed using Student’s t-text. Pearson’s
correlation was used for associations between sequential
parameters. The program SPSS19.0 for windows was
used for all statistical analyses. All P values had 2-sides,
where the P value < 0.05 was considered as statistically
significant.
Results
Levels of MIG/CXCL9, TARC/CCL17 and ratios of MIG/
TARC in study subjects
There were no significant differences between KD pa-
tients and healthy controls in age and sex (P > 0.05);
Compared with healthy controls, plasma levels of MIG/
CXCL9 (1110.16 ± 609.91 vs. 274.67 ± 142.44 ng/L,
respectively), TARC/CCL17 (720.08 ± 257.63 vs. 341.99
± 41.62 pg/ml, respectively) and the ratios of MIG/TARC
(1.44 ± 0.42 vs. 0.74 ± 0.11) were significantly increased
in patients with KD (Table 1).
General characteristics and plasma MIG/CXCL9 and TARC/
CCL17 levels, and ratios of MIG/TARC in KD-CAL and KD-
NCAL
On the comparison between KD-CAL and KD-NCAL
groups, there were no significant differences in age, sex,
WBC, Plt, N %, L %, Hct, CRP, ESR, AST, CK-MB (P >
0.05). However, a significantly decrease in hemoglobin and
an increase in plasma MIG/CXCL9, TARC/CCL17, and ra-
tios of MIG/TARC were observed in KD-CAL group com-
pared to KD-NCAL group (Table 2).
Correlations of MIG/CXCL9 and TARC/CCL17 with laboratory
variables in all KD patients
Plasma TARC/CCL17 levels in KD patients had no
significant correlation with WBC, Plt, N%, Hb, Hct,
CRP, ESR, AST, CK-MB (P > 0.05). However, plasma
MIG/CXCL9 levels were negatively correlated with
CRP (r = –0.464, p = 0.030) in KD-CAL group (Table 3,
Fig. 1) and positively associated with WBC (r = 0.591,
p = 0.005) in KD-NCAL group (Table 3, Fig. 2).
Discussion
In this study, we present a novel observation of the rela-
tionship between plasma MIG/CXCL9, TARC/CCL17
levels and coronary artery lesions in KD patients. We
have found that KD patients had significantly higher
plasma MIG/CXCL9 and TARC/CCL17 levels compared
to the healthy controls. Furthermore, plasma MIG/
CXCL9 and TARC/CCL17 levels were even higher in
KD with CAL compared to KD without CAL. The in-
creased levels of MIG/CXCL9 and TARC/CCL17 may
suggest that these markers are involved in the develop-
ment of coronary artery lesions. In addition, we have
found that Hb is significantly decreased in KD with
CAL, and plasma MIG/CXCL9 levels are negatively cor-
related with CRP in KD with CAL patients, whereas a
positive correlation between plasma MIG/CXCL9 and
WBC is observed in KD without CAL.
The etiology of KD remains unclear. Accumulated
studies indicate that bacteria or virus infections are par-
ticipated in the pathogenesis of KD [8, 9]. During the
immunoreaction to infections, T cells were abnormally
functioned. Matsubara [10] found that the numbers of
CD4+ T cells were increased and the subsets of T cells
Table 1 Plasma levels of MIG/CXCL9, TARC/CL17 and MIG/TARC
in all study subjects
KD (n = 43) Controls (n = 19) P value
Age at diagnosis(Yr) 2.98 ± 1.91 3.37 ± 3.02 0.57
Sex(male/female) 22/21 12/7 0.16
MIG/CXCL9(ng/L) 1110.16 ± 609.91 274.67 ± 142.44 <0.01
TARC/CCL17 (pg/ml) 720.08 ± 257.63 341.99 ± 41.62 <0.01
MIG/TARC 1.44 ± 0.42 0.74 ± 0.11 <0.01
KD Kawasaki disease, Yr year, MIG/CXCL9 Monokine induced by interferon-gamma,
TARC/CCL17 Thymus and activation-regulated chemokine, MIG/TARC the ratio of
plasma MIG/CXCL9 and TARC/CCL17 levels; Data are presented as Mean ± SD.
P-value is for the comparison between controls and KD patients
Table 2 General characteristics and plasma MIG/CXCL9 and
TARC/CCL17 and MIG/TARC between KD with CAL (KD-CAL) and
KD without CAL (KD-NCAL)
KD-CAL (n = 22) KD-NCAL (n = 21) P value
Age at diagnosis(Yr) 2.96 ± 2.04 3.06 ± 1.84 0.95
Sex (male/female) 15/7 7/14 0.16
WBC (103/ul) 14.31 ± 6.14 14.82 ± 4.96 0.73
Plt (103/ul) 354.91 ± 99.62 378.33 ± 130.17 0.58
N % 0.64 ± 0.20 0.67 ± 0.17 0.61
L % 0.30 ± 0.19 0.29 ± 0.14 0.89
Hb (g/L) 100.77 ± 11.23 107.71 ± 11.06 0.04*
Hct (%) 30.51 ± 3.02 31.48 ± 2.28 0.32
CRP (mg/dl) 45.41 ± 33.47 40.24 ± 34.49 0.61
ESR (mm/hour) 61.09 ± 29.95 70.05 ± 20.73 0.45
CK-MB (U/L) 1.69 ± 1.57 1.19 ± 0.48 0.17
AST (U/L) 34.70 ± 11.91 37.43 ± 20.28 0.59
MIG/CXCL9 (ng/L) 1679.03 ± 197.03 514.21 ± 107.39 <0.01
TARC/CCL17(pg/ml) 953.74 ± 106.52 475.29 ± 67.05 <0.01
MIG/TARC 1.78 ± 0.26 1.09 ± 0.20 <0.01
KD Kawasaki disease, Yr year, WBC white blood cells counts, Plt platelets
counts, N% percentage of neutrophils, L% percentage of leukomonocytes,
Hb hemoglobin, Hct hematocrit, CRP C-reactive protein, ESR erythrocyte
sedimentation rate, CK-MB creatine kinase-MB, AST aspartate aminotransferase,
MIG/CXCL9 Monokine induced by interferon-gamma, TARC/CCL17 Thymus and
activation-regulated chemokine, MIG/TARC the ratio of plasma MIG/CXCL9 and
TARC/CCL17 levels; the P value < 0.05 is considered as statistically significant
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were imbalanced. In Hahn’s study [11], T cells of KD
were cultured in vitro, and as a result, levels of IFN-γ
and IL-4, which were the representative factors of T
helper cells, had no significant changes. Kimura [12]
demonstrated that T cells were not activated and they
were inhibited in the acute period of KD. So the data are
controversial regarding the role and the balance of T
cells in KD patients.
Chemotactic factors are a class of small molecular pro-
teins that specifically collect and activate leukocytes.
They are widely found in pathological processes such as in-
flammation, immunization, angiogenesis and hemopoiesis
[13–16]. When inflammatory signals are active, chemotac-
tic factors are enhanced. They can induce leukocytes and
activate T cells migrating to inflammatory sites. Cytokines
are secreted by T cells or macrophagocytes to control the
inflammation. Plasma levels of chemotactic factors can
represent the levels of activated T cells in inflammation. Ac-
cording to the sequences of cysteine in chemistry structure,
chemotactic factors are divided into four different subfam-
ilies: Cys-X-Cys (CXC), Cys-Cys (CC), Cys (C), Cys-X-3Cys
(CX3C). MIG/CXCL9 belongs to the subfamily of CXC
and TARC/CCL17 is part of CC subfamily. MIG/CXCL9
and TARC/CCL17 are chemoattractants for Th1 and Th2
cells and specifically activate Th1 and Th2 cells. They are
up-regulated in inflammatory sites and constitutively
expressed to induce the migration of Th1 and Th2 cells to
control inflammation. So the plasma levels of MIG/CXCL9
and TARC/CCL17 can reflect the numbers of activated
Th1 and Th2 cells in vasculitis sites in KD patients. Most
reports studied cytokines levels like IFN-γ and IL- 4
secreted by Th1 and Th2 cells to evaluate the func-
tion of T cells in KD. In our study, we have tried an-
other way by measuring plasma levels of MIG/CXCL9
Table 3 Correlations of MIG/CXCL9 and TARC/CCL17 with laboratory variables in all KD patients
KD-CAL (n = 22) KD-NCAL (n = 21)
MIG/CXCL9 TARC/CCL17 MIG/CXCL9 TARC/CCL17
r p r p r p r p
WBC (103/ul) –0.338 0.511 0.081 0.721 0.591 0.005* 0.412 0.064
Plt (103/ul) –0.263 0.719 0.018 0.938 –0.165 0.475 –0.205 0.374
N % –0.025 0.915 0.113 0.625 –0.232 0.300 –0.372 0.089
L % –0.013 0.955 –0.093 0.687 0.250 0.262 0.368 0.092
Hb (g/L) 0.297 0.180 0.050 0.826 0.089 0.700 0.102 0.661
Hct (%) 0.297 0.180 –0.048 0.833 0.039 0.868 0.092 0.691
CRP (mg/dl) –0.464 0.030* –0.241 0.279 0.283 0.214 0.399 0.074
ESR (mm/hour) –0.369 0.091 0.145 0.520 0.153 0.507 –0.301 0.185
CK-MB (U/L) –0.131 0.571 –0.007 0.977 0.091 0.687 –0.168 0.455
AST (U/L) 0.230 0.317 0.206 0.370 0.178 0.427 0.280 0.207
KD Kawasaki disease, Yr year, WBC white blood cells counts, Plt platelets counts, N % percentage of neutrophils, L % percentage of leukomonocytes,
Hb hemoglobin, Hct hematocrit, CRP C-reactive protein, ESR erythrocyte sedimentation rate, CK-MB creatine kinase-MB, AST aspartate aminotransferase,
MIG/CXCL9 Monokine induced by interferon-gamma, TARC/CCL17 Thymus and activation-regulated chemokine, *, P<0.05; the P value less than 0.05 is
considered as statistically significant
Fig. 1 The correlations between plasma MIG/CXCL9 level and CRP
level in KD-CAL group
Fig. 2 The correlations between plasma MIG/CXCL9 level and WBC
count in KD-NCAL group
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and TARC/CCL17 in KD patients. In Lee CP’s report
[5], plasma TARC levels were significantly higher in
acute KD before IVIG treatment, but they found that
plasma TARC/CCL17 levels of pre-IVIG, post-IVIG,
and subacute stages did not differ significantly in the
occurrence of CAL, coronary artery aneurysm (CAA),
and the responsiveness in KD. Here, our study dem-
onstrate that plasma levels of MIG/CXCL9 and
TARC/CCL17 in patients with KD were significantly
higher than those of healthy controls. Furthermore,
the plasma levels of MIG/CXCL9 and TARC/CCL17
are even higher in KD-CAL group compared to those
in KD-NCAL group (P < 0.05). Considering the
chemotactic and proliferative effect of these molecules
on Th1 and Th2 cells, the significant increasing of
plasma levels of MIG/CXCL9 and TARC/CCL17 in
KD patients should be an indication that Th1 and
Th2 cells are activated and are positively associated
with the development of immunoreaction in acute
period of KD. T-cell activation of immunoreaction is
identified to be the critical factor in determining sus-
ceptibility and severity of KD in children [17, 18].
Previous studies about super-antigen induced by im-
munoreaction of infections indicated that abnormal acti-
vation of T cells was the initial and key procedure of KD
vascular lesions [3]. The significant increasing of plasma
MIG/CXCL9 and TARC/CCL17 in KD with CAL could ac-
tivate Th1 and Th2 cells and induce their stronger secretion
of cytokines. Wang [19] found that Th1/Th2 cytokine pro-
files identified significantly increasing of cytokines in KD
patients. We think that the stimulation of the cytokine cas-
cade and the activation of endothelial cells plus the abnor-
mal function of T cells could be the key events leading to
coronary artery lesions in the acute phase of KD.
Since Th1 and Th2 cells can be induced by MIG/
CXCL9 and TARC/CCL17 and migrate to vasculitis sites
in KD, the levels of activated Th1 and Th2 cells should
have an appropriate ratio and play a well-balanced role.
T cells are found imbalanced in many autoimmune dis-
eases. Kimura demonstrated that Th1 and Th2 cells in
KD were well-balanced [12]. However, Matsubara found
the balance of Th1/Th2 cells were altered [10]. We have
compared the ratios of MIG/TARC to reveal the balance
between Th1 and Th2 cells. The results have shown that
the ratios of MIG/TARC in KD patients are significantly
higher than those in healthy subjects. And furthermost,
we have found that MIG/TARC ratios in KD with CAL
show a significant difference compared to KD without
CAL. These data suggested that when attacked by un-
identified antigens in KD, both Th1and Th2 cells could
be increased stimulated by MIG/CXCL9 and TARC/
CCL17. However, the increasing speed of these T helper
cells is not balanced and this imbalance might mediate
immune lesions of vessels in KD patients.
Most previous studies indicated that the inflammatory
indexes such as WBC, CRP and ESR were increased, and
Hb, Plt, Hct were also changed in Kawasaki disease [20].
In our study, hemoglobin was decreased in KD with
CAL. Although we don’t know the mechanism of
hemoglobin changes for the moment, the present data
suggest that the decreased levels of hemoglobin could be
a higher risk factor for CAL in KD patients. A hypoxic
environment is induced by the decrease of hemoglobin,
which may accelerate inflammation and causing endo-
thelial cells injury. In addition, plasma MIG/CXCL9
levels in KD patients with CAL had significantly negative
correlation with CRP, whereas a positive correlation with
WBC in KD without CAL. As we know, WBC and CRP
are indexes of inflammation, high WBC and CRP indicate a
serious level of inflammation. When inflammation occurs,
MIG/CXCL9 and TARC/CCL17 can stimulate Th1 and
Th2 cells secreting cytokines to regulate the immunoreac-
tion during the development of vasculitis in KD, and so
plasma MIG/CXCL9 levels increase with the development
of a serious inflammation. However, when vasculitis de-
velops into CAL, plasma MIG/CXCL9 levels could be
negatively feedback regulated while TARC/CCL17 increase
persistently. The different increasing speed of MIG/CXCL9
and TARC/CCL17 levels may result in an imbalance of
Th1 and Th2 cells.
Conclusion
Our study demonstrates that the Th1 and Th2 cells may
be activated unevenly by plasma MIG/CXCL9 and
TARC/CCL17 in acute period of KD. The imbalance of
Th1 and Th2 cells may be a cause associated with the
development of e immune lesions of vessels in KD
patients. However, both the KD and healthy control
cases in this study are limited, we should be cautious in
interpret our data. More studies are needed with a large
number of patients and carrying out more functional
tests of T helper cells in KD patients.
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